Ghent University Academic Bibliography

Advanced

Haptoglobin 2-2, a genetic marker for therapy resistance in established essential hypertension

Joris Delanghe UGent, Daniel Duprez UGent, Marc De Buyzere, Geert Leroux-Roels UGent and Denis Clement (1992) In AMERICAN JOURNAL OF HYPERTENSION 5(suppl.). p.95A-95A
Please use this url to cite or link to this publication:
author
organization
year
type
conference (meetingAbstract)
publication status
published
subject
in
Am. J. Hypertens.
series title
AMERICAN JOURNAL OF HYPERTENSION
volume
5
issue
suppl.
pages
95A - 95A
ISSN
0895-7061
language
English
UGent publication?
yes
classification
C3
id
224595
handle
http://hdl.handle.net/1854/LU-224595
date created
2004-05-24 13:24:00
date last changed
2017-04-26 08:16:58
@inproceedings{224595,
  author       = {Delanghe, Joris and Duprez, Daniel and De Buyzere, Marc and Leroux-Roels, Geert and Clement, Denis},
  issn         = {0895-7061},
  language     = {eng},
  number       = {suppl.},
  pages        = {95A--95A},
  title        = {Haptoglobin 2-2, a genetic marker for therapy resistance in established essential hypertension},
  volume       = {5},
  year         = {1992},
}

Chicago
Delanghe, Joris, Daniel Duprez, MARC DE BUYZERE, Geert Leroux-Roels, and Denis Clement. 1992. “Haptoglobin 2-2, a Genetic Marker for Therapy Resistance in Established Essential Hypertension.” In , 5:95A–95A.
APA
Delanghe, Joris, Duprez, D., DE BUYZERE, M., Leroux-Roels, G., & Clement, D. (1992). Haptoglobin 2-2, a genetic marker for therapy resistance in established essential hypertension (Vol. 5, p. 95A–95A).
Vancouver
1.
Delanghe J, Duprez D, DE BUYZERE M, Leroux-Roels G, Clement D. Haptoglobin 2-2, a genetic marker for therapy resistance in established essential hypertension. 1992. p. 95A–95A.
MLA
Delanghe, Joris, Daniel Duprez, MARC DE BUYZERE, et al. “Haptoglobin 2-2, a Genetic Marker for Therapy Resistance in Established Essential Hypertension.” Vol. 5. 1992. 95A–95A. Print.